ATE290073T1 - Expressionsvektoren die 'hot spots'für eine verstärkte rekombinante proteinexpression in transfizierten zellen enthalten - Google Patents

Expressionsvektoren die 'hot spots'für eine verstärkte rekombinante proteinexpression in transfizierten zellen enthalten

Info

Publication number
ATE290073T1
ATE290073T1 AT99948139T AT99948139T ATE290073T1 AT E290073 T1 ATE290073 T1 AT E290073T1 AT 99948139 T AT99948139 T AT 99948139T AT 99948139 T AT99948139 T AT 99948139T AT E290073 T1 ATE290073 T1 AT E290073T1
Authority
AT
Austria
Prior art keywords
contain
expression
recombinant protein
transfected cells
hot spots
Prior art date
Application number
AT99948139T
Other languages
English (en)
Inventor
Kanakaraju Koduri
John T Miller
Pallaiah Thammana
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ATE290073T1 publication Critical patent/ATE290073T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70521—CD28, CD152
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT99948139T 1998-09-22 1999-09-07 Expressionsvektoren die 'hot spots'für eine verstärkte rekombinante proteinexpression in transfizierten zellen enthalten ATE290073T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10129298P 1998-09-22 1998-09-22
PCT/US1999/020467 WO2000017337A1 (en) 1998-09-22 1999-09-07 Expression vectors containing hot spot for increased recombinant protein expression in transfected cells

Publications (1)

Publication Number Publication Date
ATE290073T1 true ATE290073T1 (de) 2005-03-15

Family

ID=22283889

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99948139T ATE290073T1 (de) 1998-09-22 1999-09-07 Expressionsvektoren die 'hot spots'für eine verstärkte rekombinante proteinexpression in transfizierten zellen enthalten

Country Status (10)

Country Link
US (1) US6521419B1 (de)
EP (1) EP1115852B1 (de)
JP (1) JP4480893B2 (de)
AT (1) ATE290073T1 (de)
AU (1) AU762274B2 (de)
CA (1) CA2344699A1 (de)
DE (1) DE69923983T2 (de)
ES (1) ES2237943T3 (de)
IL (1) IL141878A0 (de)
WO (1) WO2000017337A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6800457B2 (en) * 1998-09-22 2004-10-05 Bristol-Myers Squibb Company Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
DK1806407T3 (da) * 2001-07-04 2010-08-16 Chromagenics Bv DNA-sekvenser med anti-repressoraktivitet
CA2385110A1 (en) * 2002-05-06 2003-11-06 University Of British Columbia Co-expression system for large functional proteins
EP1513936A2 (de) * 2002-06-14 2005-03-16 Chromagenics B.V. Verwendung von repression hemmende sequenzen in verfahren zur genexpression verbesserung
CA2722998C (en) * 2002-06-14 2014-12-02 Chromagenics B.V. A method for simultaneous production of multiple proteins; vectors and cells for use therein
ES2373549T3 (es) * 2002-12-18 2012-02-06 Chromagenics B.V. Método para mejorar la producción de proteínas.
DE60312039T2 (de) * 2002-12-20 2007-11-08 Chromagenics B.V. Mittel und methoden zur produktion eines proteins durch chromatin-öffner, die chromatin zugänglicher für transkriptionsfaktoren machen können
US20060195935A1 (en) 2004-11-08 2006-08-31 Chromagenics B.V. Selection of host cells expressing protein at high levels
US8999667B2 (en) * 2004-11-08 2015-04-07 Chromagenics B.V. Selection of host cells expressing protein at high levels
SI1809750T1 (sl) * 2004-11-08 2012-08-31 Chromagenics Bv Izbira gostiteljskih celic, ki imajo visok nivo izraĹľanja proteina
US8039230B2 (en) * 2004-11-08 2011-10-18 Chromagenics B.V. Selection of host cells expressing protein at high levels
BRPI0517380A (pt) * 2004-11-08 2008-10-07 Chromagenics Bv molécula de dna, cassete de expressão, célula hospedeira, e, métodos para gerar uma célula hospedeira que expressa um polipeptìdeo de interesse e para produzir um polipeptìdeo de interesse
KR101391457B1 (ko) 2005-12-20 2014-05-19 브리스톨-마이어스 스큅 컴퍼니 조성물 및 조성물의 제조 방법
AR058568A1 (es) 2005-12-20 2008-02-13 Bristol Myers Squibb Co Metodos para producir una composicion con moleculas ctla4-ig a partir de un medio de cultivo
EP2180915B1 (de) 2007-07-19 2017-10-04 Medical Components, Inc. Venöser zugangsport mit röntgendichten kennzeichnungsmerkmalen
WO2009058564A2 (en) 2007-11-01 2009-05-07 Maxygen, Inc. Immunosuppressive polypeptides and nucleic acids
WO2010023787A1 (ja) * 2008-08-29 2010-03-04 東洋紡績株式会社 遺伝子発現安定化エレメント
CN103305504B (zh) * 2012-03-14 2016-08-10 江苏吉锐生物技术有限公司 在仓鼠细胞中定点重组的组合物和方法
BR112017008022A2 (pt) * 2014-10-23 2018-02-20 Regeneron Pharmaceuticals, Inc. célula, polinucleotídeo, veículo, e, métodos para modificação de um genoma de células cho e para preparação de uma proteína de interesse.
JP7087061B2 (ja) * 2017-08-11 2022-06-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｈｏ細胞内の組込み部位
CN113661238B (zh) 2019-04-02 2024-08-27 中外制药株式会社 引入靶特异性外源基因的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2580812A1 (en) 1991-06-27 1993-01-07 Bristol-Myers Squibb Company Ctla4 receptor, fusion proteins containing it and uses thereof
US5844095A (en) 1991-06-27 1998-12-01 Bristol-Myers Squibb Company CTLA4 Ig fusion proteins
US5747034A (en) 1992-07-09 1998-05-05 Chiron Corporation Methods and materials for the induction of T cell anergy
US5773253A (en) 1993-01-22 1998-06-30 Bristol-Myers Squibb Company MYPPPY variants of CTL A4 and uses thereof
CZ289308B6 (cs) 1993-12-23 2001-12-12 Merck & Co., Inc. Homologní rekombinantní expresní vektor pro expresi rekombinantních genů a způsob exprese rekombinantních genů
AU708981B2 (en) 1996-01-11 1999-08-19 Immunex Corporation Expression augmenting sequence elements (ease) for eukaryotic expression systems

Also Published As

Publication number Publication date
DE69923983D1 (de) 2005-04-07
AU762274B2 (en) 2003-06-19
DE69923983T2 (de) 2006-04-06
JP2002526071A (ja) 2002-08-20
EP1115852A1 (de) 2001-07-18
JP4480893B2 (ja) 2010-06-16
CA2344699A1 (en) 2000-03-30
WO2000017337A1 (en) 2000-03-30
EP1115852B1 (de) 2005-03-02
IL141878A0 (en) 2002-03-10
AU6137599A (en) 2000-04-10
EP1115852A4 (de) 2002-09-25
US6521419B1 (en) 2003-02-18
ES2237943T3 (es) 2005-08-01

Similar Documents

Publication Publication Date Title
ATE290073T1 (de) Expressionsvektoren die 'hot spots'für eine verstärkte rekombinante proteinexpression in transfizierten zellen enthalten
DE69936104D1 (de) Nukleinsäuresequenzen des adeno-assoziierten virus des serotyps i, und vektoren und wirtszellen, die diese enthalten
Boer et al. Polymorphisms in the coding and noncoding regions of murine Pgk-1 alleles
Virgin et al. The gene for the beta subunit of bovine luteinizing hormone encodes a gonadotropin mRNA with an unusually short 5'-untranslated region.
BR9804896A (pt) Dna isolado e purificado, célula hospedeira, vetor, polinucleotídeo quimérico, plasmídeo e processo para aumentar a transcrição de um gene de interesse em uma célula hospedeira
DE69535703D1 (de) Aav-vermittelte überbringung von dna in zellen des nervensystems
EP0804609A4 (de) NEUARTIGE AUF p53 ANSPRECHENDE GENE
BR9509202A (pt) Sequéncia de nucleotídeo isolada vetor de transformaç o célula de planta construção de ácido nucléico e processo de usar uma construção de ácido nucléico
FI962268A0 (fi) Homologinen, rekombinanttinen vasta-aineilmentämisjärjestelmä rottien tai hiirien soluille
CA2311643A1 (en) Compositions and methods for inducing gene expression
Wonderling et al. Binding sites for adeno-associated virus Rep proteins within the human genome
EP1011717A4 (de) Arginin deiminase aus mycoplasma arthirtidis und sie enthaltende polymerkonjugate
ATE284969T1 (de) Rekombinante adenovirale vektoren, die eine spleissequenz enthalten
DE69535696D1 (de) Tripeptidyl-aminopeptidase
BR0316510A (pt) Vetor de expressão, processo para a preparação de produtos gênicos heterólogos e processo de seleção para células recombinantes de alta produção
ATE288488T1 (de) Zusammensetzungen und verfahren zur eliminierung unerwünschter zellen
ZA200404424B (en) Genes encoding for genetic stability, gene expression and folding proteins.
DE69940267D1 (de) Wirtszellen, die rekombinantes humanes erythropoietin exprimieren
WO1998025957A3 (en) Human prt1-like subunit protein (hprt1) and human eif4g-like protein (p97) genes
EP0924295A3 (de) DNS kodierend für Neospora Dihydrofolatreductase-Thymidylate Synthase
EP1571215A3 (de) Gene und Proteine von vertebraten Telomerasen, und deren Verwendungen
Chan et al. The primary structure of rat ribosomal protein S25
Vosberg et al. REGULATION OF THE HUMAN B-MYOSIN HEAVY CHAIN GENE AND AN APPROACH TO A FUNCTIONAL ANALYSIS OF RECOMBINANT PROTEIN SUBREGIONS OF THE B-CHAIN
GB2409680A (en) Methods for controlling proliferation of cells
WO2004003209A3 (fr) Acide nucleique isole du 5'ntr du gene fgf-1 humain presentant une activite ires

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1115852

Country of ref document: EP